SPECIAL CHEMISTRY

MR No. : 200100094446 Patient No. : 012006023977 Dept. No. : 037200607731

Name : MR. MUHAMMAD YASIR Room No. : Collection on : 25-06-20 07:08 PM
Gender : Male Age : 36 Years Reported on : 25-06-20 09:10 PM
Consultant : RMO Company : PRIVATE PATIENT
Test Name Result Normal Range
ANTI SARS COV2 se.
u rpo
Anti SARS CoV2 al p
REACTIVE
. or leg
id f
l
INTERPRETATION :
o t va
Non Reactive: .N
• No antibodies to SARS-CoV-2 detected. m ent
• This test should not be used to diagnose ocu SARS-CoV-2 infection, as this is for seroprevalence only. Non Reactive
dactive
e d
at
results may occur in serum collected
g e ner in the first week of infection, in immunosuppressed patients or in some individuals
with prior mild illness. r-
ute
mpa molecular test is highly recommended in symptomatic patients.
• Follow-up testing with
co
sa
is i
Th
Reactive:
• SARS-CoV-2 antibodies detected.
• This test should not be used to diagnose active SARS-CoV-2 infection. as this is for seroprevalence only.
• Reactive results suggest recent or prior infection, exposure or recovery from SARS-CoV-2.
• Protective immunity cannot be inferred based on these results alone.
• Correlation with epidemiologic risk factors and other clinical and laboratory findings is recommended.

Remarks:
This qualitative assay detects both IgG and IgM as total antibodies targeted against nucleocaspid (N) antigen performed on
fully automated Cobas e411 analyzer using electrochemiluminescence technology with FDA approved kits.